endometriosis
Proteomics International Planning Australia Launch of Endometriosis Test in Q2; US Launch to Follow
Premium
The proteomic blood test could be a noninvasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose.
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.
Endometriosis is associated with debilitating pain and increased risk of cancer and autoimmune diseases, yet diagnosis remains out of reach for many patients.
RADx Tech Launches $3M Endometriosis Dx Challenge
The challenge is open to US-based developers, and submissions require a working prototype and proof-of-concept data.
Proteomics International Inks Deal With Oxford for Endometriosis Samples
The company plans to use the roughly 600 patient plasma samples to validate its PromarkerEndo proteomic test for the condition.
May 14, 2021
Mar 22, 2018
Dec 2, 2016